Subscribe

For An International Cooperative Clinical Trial, If The Summary Report Or Other Trial Data Provided To Other Entities (Chinese Entities) Other Than The Cooperative Parties, Whether Is It Open For Use, Or Need Do Information Backup And Filing?

2022-06-16

It is not the providing to overseas nor open for use, so there is no need for information backup and filing.

Suggested Reading

What factors may affect biocompatibility risk when using biological test data from similar devices for…
What are the key focus areas in the evaluation of acute, subacute, subchronic, and chronic toxicity, and can…
Can products made from materials conforming to YY 0341.1 Appendix B be exempted from biological evaluation?
How should the evaluation of new items in the endpoint table be considered after the implementation of the new…
Under what conditions can the extraction liquid of dressings be accepted after pH adjustment, centrifugation,…
Do all medical devices require chemical characterization?
Why is the extraction period typically 24 hours in China for cytotoxicity testing?
When combining subchronic and implantation tests in one project, what factors need to be considered, and how can…
For subchronic systemic toxicity studied via implantation, what is the basis for determining the implantation…
GB/T 16886.1-2022 includes implantation in the biological evaluation of dressings. How should implantation tests…
GB/T 16886.11-2021 adds tests for subchronic systemic toxicity evaluation with dual-route exposure. Which…
How is the endotoxin limit for wound dressing products determined?

Previous: If the data statistics company needs to receive the information of human genetic resources, does it need to do information back up and filing?

Next: Can the end time of external provision of information backup and filing be later than the deadline of international cooperation?